Academic literature on the topic 'Allo-reactivity'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Allo-reactivity.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Allo-reactivity":
Huisman, Wesley, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, J. H. Frederik Falkenburg, and Inge Jedema. "The Scope of Allo-HLA Cross-Reactivity By (Third Party) Virus Specific T Cells Is Surprisingly Affected By HLA Restriction Rather Than Virus Specificity." Blood 132, Supplement 1 (November 29, 2018): 2048. http://dx.doi.org/10.1182/blood-2018-99-116028.
Webb, S. R., J. H. Li, I. MacNeil, P. Marrack, J. Sprent, and D. B. Wilson. "T cell receptors for responses to Mls determinants and allo-H-2 determinants appear to be encoded on different chromosomes." Journal of Experimental Medicine 161, no. 1 (January 1, 1985): 269–74. http://dx.doi.org/10.1084/jem.161.1.269.
Amir, Avital L., Lloyd J. A. D'Orsogna, Dave L. Roelen, Marleen M. van Loenen, Renate S. Hagedoorn, Renate de Boer, Menno A. W. G. van der Hoorn, et al. "Allo-HLA reactivity of virus-specific memory T cells is common." Blood 115, no. 15 (April 15, 2010): 3146–57. http://dx.doi.org/10.1182/blood-2009-07-234906.
Huisman, Wesley, Didier A. T. Leboux, Lieve E. van der Maarel, Lois Hageman, Derk Amsen, Fred Falkenburg, and Inge Jedema. "Off-Target HLA Cross-Reactivity By (Third Party) Virus-Specific T Cells Is Surprisingly Affected By HLA Restriction and HLA Background but Not By Virus Specificity." Blood 134, Supplement_1 (November 13, 2019): 4440. http://dx.doi.org/10.1182/blood-2019-124785.
Hasenkamp, Justin, Andrea Borgerding, Bjoern Chapuy, Gerald Wulf, Inga Missal, Wolfram Jung, Lorenz Truemper, and Bertram Glass. "Allo-Reactive NK Cells after HLA-Matched Allogeneic Hematopoietic Stem Cell Transplantation." Blood 108, no. 11 (November 16, 2006): 2904. http://dx.doi.org/10.1182/blood.v108.11.2904.2904.
Webb, S. R., A. Okamoto, and J. Sprent. "Analysis of T hybridomas prepared from a T cell clone with three specificities. Recognition of self + X and allo-H-2 determinants segregates from recognition of Mlsa determinants." Journal of Immunology 141, no. 6 (September 15, 1988): 1828–34. http://dx.doi.org/10.4049/jimmunol.141.6.1828.
Elkon, Keith B., and Dalit Ash Any. "Autoimmunity Versus Allo- and Xeno-Reactivity in SCID Mice." International Reviews of Immunology 11, no. 4 (January 1994): 283–93. http://dx.doi.org/10.3109/08830189409051175.
Laghmouchi, Aicha, Conny Hoogstraten, Peter Van Balen, Rick van de Water, Marian van de Meent, J. H. Frederik Falkenburg, and Inge Jedema. "The Allo-HLA-DP Restricted T Cell Repertoire Contains a Variety of Tissue-Restricted Specificities with Therapeutic Value." Blood 128, no. 22 (December 2, 2016): 3356. http://dx.doi.org/10.1182/blood.v128.22.3356.3356.
Noonan, Kimberly, Leo Luznik, and Ivan M. Borrello. "Enrichment of Allogeneic Tumor Antigen-Specific T Cells From Bone Marrow (BM) of Patients Treated with High-Dose Post-Transplant Cyclophoshamide (Cy) – A Novel Approach to Adoptive Immunotherapy." Blood 118, no. 21 (November 18, 2011): 647. http://dx.doi.org/10.1182/blood.v118.21.647.647.
D’Orsogna, Lloyd, Heleen van den Heuvel, Cees van Kooten, Sebastiaan Heidt, and Frans H. J. Claas. "Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms." Immunogenetics 69, no. 8-9 (July 17, 2017): 631–41. http://dx.doi.org/10.1007/s00251-017-0989-3.
Dissertations / Theses on the topic "Allo-reactivity":
Nattes, Tristan de. "Rejet humoral d'allogreffe rénale et allo-immunisation HLA." Electronic Thesis or Diss., Normandie, 2023. http://www.theses.fr/2023NORMR053.
Kidney transplantation is the best treatment of end-stage renal disease, improving life quality and quantity. Despite advances in pathophysiological knowledge of kidney transplant immunology, kidney transplant rejection remains the major cause of allograft dysfunction, especially antibody-mediated rejection.Antibody-mediated rejection risk assessment is based on the evaluation of donor-specific anti-HLA antibodies. However, these antibodies have a poor predictive value for incidence and prognosis of rejection. This could be explained by the heterogeneity of their intrinsic characteristics. These characteristics depend on cells responsible for their secretion, which include short- and long- lived plasma cells. Consequently, they indirectly depend on the cells responsible for maintaining the pool of these antibody-secreting cells, such as memory B cells. In infectious diseases, it is known that memory B cells are heterogeneous in terms of phenotype, function, degree of clonality, and diversification of their B-cell receptor (BCR). However, this heterogeneity has not been examined in the context of kidney transplantation.The aim of the first part of this thesis was to study the heterogeneity of HLA-specific memory B cells in sensitised patients on kidney transplant waiting list. To this end, single-cell analysis of HLA-specific memory B cells from patients with various aetiologies and degrees of immunisation was performed. This led to their phenotypic and transcriptomic characterisation and to the assessment of their BCR repertoire.The second part of this thesis was dedicated to the diagnosis of kidney transplant rejection.In recent years, biopsy-based transcriptomics has emerged, enabling the assessment of hundreds of transcripts in kidney biopsy tissue. These tools provide the opportunity to elucidate new physiopathological pathways and potentially enhance the diagnosis of rejection, especially humoral rejection. However, their application in clinical practice is still limited due to their restricted availability, required expertise for data processing and interpretation, and cost. Furthermore, their exact impact on patient management remains undetermined. Here, a molecular diagnostic tool with characteristics suitable for clinical use was developed. This tool enables the diagnosis of rejection and its classification between antibody-mediated and T-cell mediated rejection. Subsequently, this tool was assessed in ambiguous clinical situations to evaluate its impact in clinical practice.Through these studies, this thesis focused on enhancing our understanding of the humoral response in renal transplantation, which could help improving immunological risk stratification in transplantation. Additionally, it aimed to improve biopsy-based transcriptomics in the diagnosis of kidney transplant rejection
Book chapters on the topic "Allo-reactivity":
D’Orsogna, Lloyd J., Ellen M. W. van der Meer-Prins, Yvonne M. Zoet, Dave L. Roelen, Ilias I. N. Doxiadis, and Frans H. J. Claas. "Detection of Allo-HLA Cross-Reactivity by Virus-specific Memory T-Cell Clones Using Single HLA-Transfected K562 Cells." In Methods in Molecular Biology, 339–49. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-842-9_19.
Conference papers on the topic "Allo-reactivity":
Howie, Duncan, Terri V. Cornforth, Nathifa Moyo, Suzanne Cole, Emily Lam, Tatiana Lobry, Ron Wolchinsky, et al. "362 Allelic variants of MR1 drive cancer and allo-reactivity by MR1-restricted T cells." In SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0362.